Pinned Tweet
We’ve brought together 25 clinical guidelines and 16 quality standards on women’s health in one place, making evidence easier to find, use and act on
Explore how this work supports the government’s Women’s Health Strategy 👇
orlo.uk/OgJ7e
NICE retweeted
Thousands of people have already benefited from capsule sponge tests through NHS pilots.
Now, new draft NICE guidance could see the quick, less invasive test offered more widely across England to help detect oesophageal cancer earlier.
➡️ nice.org.uk/news/articles/le…
What if clinicians could access the NICE guidance they need, directly within the systems they use every day?
We’re partnering with @MFTnhs, exploring how evidence, digital innovation and clinical guidance can work together to support better care⤵️
orlo.uk/dilLa
A less invasive test could help detect oesophageal cancer earlier.
Our draft guidance recommends capsule sponge tests for some people at higher risk. They don't require sedation and can be carried out closer to home.
Find out more: nice.org.uk/news/articles/le…
The recommendations are the first through the new National HealthTech Access Programme.
This technology could make testing easier for patients while helping the NHS focus valuable endoscopy capacity on those who need it most.
Have your say by 7 Dec: nice.org.uk/news/articles/le…
396
NICE and @NHSEngland are piloting a new approach to managed access for promising medicines.
SMART aims to help suitable treatments reach patients sooner while further evidence is gathered about how well they work in practice.
Find out more: orlo.uk/lZ6av

ALT A prescription being handed over a pharmacy counter. Overlaid text reads: A new approach to provide promising medicines to NHS patients sooner - NICE and NHS England are testing a new way of making some promising medicines available to patients sooner Known as the Streamlined Managed Access Route for Therapies (SMART) pilot
Around 250 people with advanced anal cancer could benefit from a new life-extending treatment recommended by NICE and available on the NHS from today.
It’s the first NICE-recommended drug for this specific form of anal cancer.
Read more: orlo.uk/0OsZd
As part of our work to bring NICE guidance together in high priority areas, we’ve added medicines recommendations to our ovarian cancer guideline, giving easy access at the right point in the guideline.
🔗orlo.uk/q1EUC
#NICEWomensHealth
NHS commissioners in @BlackCountryICS increased uptake in childhood immunisations from 64.4% to 76.8%.
Learn how they utilised a NICE quality standard to communicate with families in their first language.
orlo.uk/l095S
#WorldImmunisationDay
What is NICE’s Forward View?
Our CMO, Dr Adrian Hayter explains how we identify the topics that matter most to the health and care system.
Find out more: orlo.uk/ZE9Qi
Our Forward View helps us focus on the areas where we can make the greatest difference.
We’ve refreshed it to reflect our latest guidance and strategic priorities, alongside updates across individual topics areas👇
nice.org.uk/what-nice-does/o…
384
People with an aggressive form of bladder cancer could be set to benefit after we recommended a new treatment, that can be taken before and after surgery, in final draft guidance published today.
Find out more about pembrolizumab: orlo.uk/boPtH
We’ve brought together 25 clinical guidelines and 16 quality standards on women’s health in one place, making evidence easier to find, use and act on
Explore how this work supports the government’s Women’s Health Strategy 👇
orlo.uk/Vl7rq
NICE retweeted
The Innovation Scorecard has been updated with data to June 2026.
It covers the use of selected @NICEComms recommended medicines across the NHS in England.
It helps NHS teams and researchers understand changes over time and differences between areas.
media.nhsbsa.nhs.uk/press-re…
Around 670 people in England could benefit from a treatment for severe, debilitating itching caused by Alagille syndrome.
Maralixibat is taken as a liquid and can help treat cholestatic pruritus, which can severely affect sleep and quality of life.
🔗 orlo.uk/pdjb7
4
1,457
Hundreds of people with a rare inherited genetic disorder that causes high build-ups of fat in the blood are set to benefit after NICE recommended two new treatments in final guidance published today.
Find out more about olezarsen and plozasiran: nice.org.uk/guidance/TA1203
NICE retweeted
The Health Economics Methods Advisory (#HEMA) today released a Draft Report on how HTA bodies can evaluate, present, and communicate uncertainty in #healtheconomic evaluations. #hta #populationhealth
Now accepting public comments until Nov 2. Read more: shorturl.at/mOe0F
NHS use of NICE-recommended tablets for endometriosis and fibroids has more than tripled in a year, from 1.2m to 3.7m tablets.
Behind that rise are women finding new ways to manage painful and debilitating symptoms:
orlo.uk/LhPz9
#NICEWomensHealth

ALT Graphic showing that NHS use of NICE-recommended tablets for endometriosis and fibroids has more than tripled in a year, rising from 1.2 million to 3.7 million tablets. A line chart shows use increasing sharply between 2024 and 2026. More than 12,000 people also received GP prescriptions in England in 2025/26, almost three times the previous year.
For Clare, who lives with endometriosis, treatment helped her manage severe pain while waiting for surgery.
Read Clare, Lucy and Ruth’s stories, and explore the data: nice.org.uk/news/articles/-i…
463
More than 58,000 people were diagnosed with prostate cancer in England in 2023.
New AI tools could support radiologists interpreting prostate MRI scans, helping them spot possible cancer more accurately.
Read our draft guidance: nice.org.uk/guidance/indevel…
















